Product
Isosorbide Dinitrate
Name
Isosorbide Dinitrate
INN Name
isosorbide dinitrate
FDA Approved
Yes
5 clinical trials
2 organizations
9 indications
2 documents
Indication
Hypertensive Heart FailureIndication
TachycardiaIndication
Chronic Orthostatic IntoleranceIndication
Congestive Heart FailureIndication
Congestive heart failureIndication
Pulmonary EdemaIndication
Heart FailureIndication
Acute Heart FailureIndication
Heart DecompensationClinical trial
The Evidence-based Treatment of Hypertensive Heart Failure in Sub-Saharan Africa: A Feasibility StudyStatus: Completed, Estimated PCD: 2024-02-26
Clinical trial
Treatment of Orthostatic IntoleranceStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts (DART-HA)Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Vasodilation or Loop-diuretics for Initial Treatment of Pulmonary Edema or Congestion Due to Acute Heart Failure - a Randomized Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Comparison of Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in Patients With Acute Decompensated Heart Failure: A Randomized Controlled TrialStatus: Withdrawn, Estimated PCD: 2021-12-01
Organization
Physicians Total Care, Inc.Organization
Advagen Pharma Ltd